REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 151 filers reported holding REVOLUTION MEDICINES INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,247 | +3.5% | 3,152 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $84,316 | +175558.3% | 3,152 | +42.6% | 0.00% | – |
| Q1 2023 | $48 | -9.4% | 2,210 | 0.0% | 0.00% | – |
| Q4 2022 | $53 | -99.9% | 2,210 | 0.0% | 0.00% | – |
| Q3 2022 | $45,000 | +7.1% | 2,210 | +2.8% | 0.00% | – |
| Q2 2022 | $42,000 | +16.7% | 2,150 | +53.6% | 0.00% | – |
| Q1 2022 | $36,000 | -29.4% | 1,400 | -41.2% | 0.00% | – |
| Q4 2021 | $51,000 | -25.0% | 2,380 | -3.6% | 0.00% | – |
| Q3 2021 | $68,000 | -12.8% | 2,470 | 0.0% | 0.00% | – |
| Q2 2021 | $78,000 | +13.0% | 2,470 | +64.7% | 0.00% | – |
| Q1 2021 | $69,000 | +16.9% | 1,500 | 0.0% | 0.00% | – |
| Q4 2020 | $59,000 | -7.8% | 1,500 | -18.0% | 0.00% | -100.0% |
| Q3 2020 | $64,000 | – | 1,829 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 685,011 | $13,508,000 | 35.31% |
| TRV GP III, LLC | 3,604,130 | $71,073,000 | 31.03% |
| Nextech Invest Ltd. | 4,189,529 | $82,618,000 | 26.68% |
| Column Group LLC | 4,577,840 | $90,275,000 | 19.98% |
| Ponoi Management, LLC | 685,011 | $13,508,000 | 18.44% |
| TRV GP IV, LLC | 1,419,900 | $28,000,000 | 16.36% |
| Boxer Capital, LLC | 3,984,264 | $78,570,000 | 4.42% |
| Casdin Capital, LLC | 2,522,300 | $49,740,000 | 3.27% |
| Cormorant Asset Management, LP | 1,995,066 | $39,343,000 | 2.75% |
| BVF INC/IL | 3,255,588 | $64,200,000 | 2.65% |